| Previous Close | 4.55 |
| Open | 4.38 |
| Volume | 10,318 |
| Avg. Volume (3M) | 18,546 |
| Market Cap | 38,830,112 |
| Price / Sales | 0.020 |
| 52 Weeks Range | |
| Earnings Date | 28 Nov 2025 |
| Profit Margin | -0.48% |
| Diluted EPS (TTM) | -2.18 |
| Total Debt/Equity (MRQ) | 51.66% |
| Current Ratio (MRQ) | 1.14 |
| Operating Cash Flow (TTM) | 267.18 M |
| Levered Free Cash Flow (TTM) | -167.84 M |
| Return on Assets (TTM) | -0.03% |
| Return on Equity (TTM) | -7.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (US) | Mixed | Mixed |
| Medical Distribution (Global) | Bullish | Mixed | |
| Stock | 111, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.38 |
|
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| % Held by Insiders | 15.84% |
| % Held by Institutions | 23.69% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Serenus Wealth Advisors, Llc | 30 Jun 2025 | 4,563 |
| Deuterium Capital Management, Llc | 30 Jun 2025 | 0 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 17 Sep 2025 | Announcement | 111, Inc. Announces Second Quarter 2025 Unaudited Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |